Test pricing and billing
The cost of the Galleri® test may vary depending on the healthcare practice or provider who orders the test. The list price for the Galleri test is $949.
Most health insurance plans do not cover the cost of the Galleri test.
How to pay your bill
If you have received a bill for the Galleri test and need to make a payment, you can do so through one of the convenient methods listed below. A flexible payment plan may also be available. Contact our Billing Support Team for more information at 858-333-5986.
Pay online
Visit our billing portal to pay your bill online by credit card or eCheck
Pay by phone
Please contact our Billing Support Team at 858-333-5986.
Pay by mail*
A check made payable to GRAIL, Inc. can be mailed to:
GRAIL, Inc.
Dept LA 25195
Pasadena, CA 91185-5195
*Before mailing your check, make sure to do the following:
1. Write your billing statement number on the memo line
2. Include the detachable bottom of your billing statement in the envelope
Self-pay options
Explore payment options to determine which is right for you.
The Galleri test is not covered by most health insurance plans at this time.FSA/HSA
You may be able to use pre-tax dollars in your flexible spending account (FSA) or health savings account (HSA) to pay for the Galleri test. Check with your FSA or HSA administrator or insurance provider to determine eligibility.
Payment plan
A flexible payment plan may assist you with 0% interest for up to 12 months. Learn how to enroll by calling GRAIL Customer Service at (833) 694‑2553
The cost of the Galleri test does not include additional diagnostic testing to confirm cancer. If you need help obtaining insurance coverage for diagnostic tests, please contact the GRAIL patient advocate, patient-advocate@grailbio.com for assistance.
The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment.
Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer.
If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Rx only.
The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed — and its performance characteristics were determined — by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.